在线与面诊管理特应性皮炎对生活质量与就医可及性的影响:随机对照试验
该12个月实用随机对照等效性试验纳入300例≥1岁医生诊断的特应性皮炎患者,1:1随机分至在线团队连接健康组或面诊组。
要点
- 在线团队连接健康模式在改善特应性皮炎患者生活质量方面与面诊管理等效
- 在线模式显著缩短基线评估所需时间
- 该模式可作为特应性皮炎远程管理的一种有效选择
核心结论
- 在线团队连接健康模式使特应性皮炎患者获得与面诊管理等效的生活质量改善,并缩短基线评估所需时间。
研究设计与样本
- 12个月实用随机对照等效性试验(NCT03981926),纳入300例年龄≥1岁、医生诊断的特应性皮炎患者,1:1随机分至在线组或面诊组。
主要发现
- 生活质量所有指标组间平均变化差异均落在预设等效界内:DLQI差异0.12(95%CI -0.18至0.42),效用指数差异0.00(95%CI -0.01至0.01),VAS差异-0.11(95%CI -0.70至0.48)。
关键数值与推荐
- 生活质量等效性预设界:DLQI差异0.12(95%CI -0.18至0.42),效用指数差异0.00(95%CI -0.01至0.01),VAS差异-0.11(95%CI -0.70至0.48),均落在等效界内。
临床怎么用
- 对于特应性皮炎患者,可考虑采用在线团队连接健康模式进行管理,以在保证生活质量改善等效的同时缩短评估时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atopic dermatitis is a chronic skin disease that can significantly affect quality of life (QOL) and requires regular access to dermatologic care. However, traditional in-person visits often impose logistical challenges. OBJECTIVES: The aim of this study was to evaluate whether an online, team-based connected health teledermatology model provides improvements in QOL equivalent to those provided by in-person management of atopic dermatitis and to examine access to care. METHODS: We conducted a 12-month, pragmatic, randomized, controlled equivalence trial (NCT03981926) involving 300 participants aged ≥1 year with physician-diagnosed atopic dermatitis. Participants were randomized 1:1 to the online or in-person arm. QOL was assessed using the Dermatology Life Quality Index and EQ-5D-5L. Access was measured through the average time needed for evaluation. RESULTS: For all QOL measures, the difference in mean change between arms fell within the prespecified equivalence margins: 0.12 (95% confidence interval = -0.18 to 0.42) for Dermatology Life Quality Index, 0.00 (95% confidence interval = -0.01 to 0.01) for utility index, and -0.11 (95% confidence interval = -0.70 to 0.48) for Visual Analog Scale. Team-based connected health significantly reduced the time needed for evaluation at baseline (P = .03). CONCLUSION: For patients with atopic dermatitis, the online team-based connected health model resulted in equivalent improvements in QOL and reduced the time needed for evaluation at baseline.
引用
- Armstrong AW, Roberts AM, Kostandy G, et al. Impact of online versus in-person management of atopic dermatitis on QOL and access to care: A randomized controlled trial. J Invest Dermatol. 2026. PMID: 42362079. doi:10.1016/j.jid.2026.06.1277
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。